Title : Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells - Riganti_2005_Br.J.Pharmacol_146_1096 |
Author(s) : Riganti L , Matteoni C , Di Angelantonio S , Nistri A , Gaimarri A , Sparatore F , Canu-Boido C , Clementi F , Gotti C |
Ref : British Journal of Pharmacology , 146 :1096 , 2005 |
Abstract : Riganti_2005_Br.J.Pharmacol_146_1096 |
ESTHER : Riganti_2005_Br.J.Pharmacol_146_1096 |
PubMedSearch : Riganti_2005_Br.J.Pharmacol_146_1096 |
PubMedID: 16273122 |
Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C (2005)
Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells
British Journal of Pharmacology
146 :1096
Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C (2005)
British Journal of Pharmacology
146 :1096